Efficacy and safety of palonosetron as salvage treatment in the prevention of chemotherapy-induced nausea and vomiting in patients receiving low emetogenic chemotherapy (LEC)

被引：0
作者：
Paul J. Hesketh
Gary Morrow
Anna W. Komorowski
Raza Ahmed
David Cox
机构：
[1] Lahey Clinic Medical Center,Department of Hematology Oncology
[2] University of Rochester School of Medicine and Dentistry,undefined
[3] Hematology-Oncology Associates of Rockland County,undefined
[4] Eisai,undefined
[5] Inc,undefined
[6] Eisai,undefined
[7] Inc,undefined
来源：
Supportive Care in Cancer | 2012年 / 20卷
关键词：
Palonosetron; Serotonin antagonists; Nausea and vomiting; Low emetogenic chemotherapy; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2633 / 2637
页数：4
相关论文
共 50 条
[21]   Palonosetron Hydrochloride in the Treatment of chemotherapy-Induced nausea and Vomiting [J].
Li, Quan ;
Roddy, Julianna V. F. ;
Berger, Michael .
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 :1145-1158
[22]   Pharmacokinetic profile and safety of intravenous NEPA, a fixed combination of fosnetupitant and palonosetron, in cancer patients: Prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy [J].
Kurteva, Galina ;
Chilingirova, Nataliya ;
Rizzi, Giada ;
Caccia, Tatiana ;
Stell, Valentino ;
Bernareggi, Alberto .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 139
[23]   Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy [J].
Miya, Toshimichi ;
Kobayashi, Kunihiko ;
Hino, Mitsunori ;
Ando, Masahiro ;
Takeuchi, Susumu ;
Seike, Masahiro ;
Kubota, Kaoru ;
Gemma, Akihiko .
SPRINGERPLUS, 2016, 5
[24]   Phase II Study on EANI Combined with Hydrochloride Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting Following Highly Emetogenic Chemotherapy [J].
Xiao, Yang ;
Liu, Jun ;
Liu, Yang-Chen ;
Huang, Xin-En ;
Guo, Jian-Xong ;
Wei, Wei .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (09) :3951-3954
[25]   Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer [J].
Murakami, Michiyasu ;
Hashimoto, Hiroki ;
Yamaguchi, Kyohei ;
Yamaguchi, Ikuko ;
Senba, Shozo ;
Siraishi, Takeshi .
SUPPORTIVE CARE IN CANCER, 2014, 22 (04) :905-909
[26]   Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting [J].
Gillian M. Keating .
Drugs, 2015, 75 :2131-2141
[27]   Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting [J].
Keating, Gillian M. .
DRUGS, 2015, 75 (18) :2131-2141
[28]   Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy [J].
Affronti, Mary Lou ;
Bubalo, Joseph .
CANCER MANAGEMENT AND RESEARCH, 2014, 6 :329-337
[29]   Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis [J].
Yamaguchi, Atsushi ;
Saito, Yoshitaka ;
Takekuma, Yoh ;
Sugawara, Mitsuru .
SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
[30]   Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy [J].
Gao, Ai ;
Guan, Shasha ;
Sun, Yinjuan ;
Wang, Lingling ;
Meng, Fanlu ;
Liu, Xia ;
Gu, Liyan ;
Li, Guo ;
Zhong, Diansheng ;
Zhang, Linlin .
BMC CANCER, 2023, 23 (01)
12345